Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer

The intractability of non-small cell lung cancer (NSCLC) to multimodality treatments plays a large part in its extremely poor prognosis. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cytokine for selective induction of apoptosis in cancer cells; however, many NSCLC c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Guo, Liangran, Fan, Li, Ren, Jinfeng, Pang, Zhiqing, Ren, Yulong, Li, Jingwei, Wen, Ziyi, Qian, Yong, Zhang, Lin, Ma, Hang, Jiang, Xinguo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356168/
https://ncbi.nlm.nih.gov/pubmed/22619505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S24711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars